Biography
Professor Stephen Fox: Head, Molecular Pathology Laboratory, is also currently Director of Pathology at Peter Mac and Professorial Fellow in the Department of Pathology, The University of Melbourne. He took an Honors Degree and Medical Degree at the University of Bristol, UK (1986), before completing Pathology training in Oxford, UK after which he was awarded a Fellowship of the Royal College of Pathologists, UK, by examination, on first attempt in 1994. He was awarded a DPhil in Medicine at the University of Oxford in 1996 for work in angiogenesis and human cancer. He moved to Christchurch, New Zealand in 1996 as a Specialist Anatomical Pathologist and Senior Lecturer at the University of Otago and established the de novo and angiogenesis research laboratory. He returned to Oxford in 2001 as Clinical Reader in Pathology as part of the CRUK Chemopathology Group, while still coordinating the Christchurch laboratory. In February 2006 he moved to Melbourne, passed the Fellowship of the Royal College of Australasia by examination on first attempt and has recently been awarded a Fellowship in the Faculty of Science in the RCPA.
He has numerous positions of responsibility both within Peter Mac, state-based organisations and international organisations. He is a member of numerous relevant professional organisations; he reviews widely for numerous journals and grant review bodies, and is editor for three pathology journals. He sits on many pharmaceutical advisory boards for breast, lung and some gastrointestinal tumours.
Currently he has a laboratory which he established at Peter Mac focusing on prognostic and predictive markers together with the molecular pathology of cancer. Being a Clinical Pathologist, he focused on translating many of the new genomic tests including KRAS, BRAF, ALK and HER2 in colorectal, breast, lung and melanoma. He publishes widely in numerous high-impact journals, has a strong publication record in excess of 180 articles, citations in excess of 9000 (Scopus) and has an H-index of 45. He is recognised as an expert in breast and molecular pathology.
